article thumbnail

Gene sequencing for lung cancer under-used in Europe

pharmaphorum

Gene sequencing for lung cancer under-used in Europe Phil.Taylor Mon, 10/07/2023 - 09:37 Bookmark this

article thumbnail

PacBio Secures $900 Million Investment to Support Gene Sequencing

BioSpace

will make an investment of $900 million into the company to support its gene sequencing research. Shares of Pacific Biosciences soared more than 21% in premarket trading after it was announced SB Management, a subsidiary of SoftBank Group Corp.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA approves first liquid biopsy test that uses advanced gene sequencing

Bio Pharma Dive

The test, developed by Guardant Health, combines next-generation sequencing with a cancer blood test.

article thumbnail

Ring 20: Could the rare disease get left behind by next-generation gene sequencing?

pharmaphorum

Ring Chromosome 20 Syndrome, or (R)20, is an ultra-rare form of epilepsy with a devastating impact – yet despite huge leaps forward in gene sequencing in recent years, diagnoses are going down instead of up. The post Ring 20: Could the rare disease get left behind by next-generation gene sequencing? appeared first on.

article thumbnail

Companion Diagnostics Markets, 2025 – Immunohistochemistry, Polymerase Chain Reaction, In-situ Hybridization, Real-time PCR, Gene Sequencing – ResearchAndMarkets.com

BioTech 365

Companion Diagnostics Markets, 2025 – Immunohistochemistry, Polymerase Chain Reaction, In-situ Hybridization, Real-time PCR, Gene Sequencing – ResearchAndMarkets.com Companion Diagnostics Markets, 2025 – Immunohistochemistry, Polymerase Chain Reaction, In-situ Hybridization, Real-time PCR, Gene Sequencing – ResearchAndMarkets.com (..)

article thumbnail

Gene sequencing identifies rare pediatric disorders in Mexico

BioPharma Reporter

A new genetic sequencing technology from Element Biosciences has helped researchers from the Translational Genomics Research Institute (TGen), part of the City of Hope, identify the likely genetic causes of disorders in six of nine children from Sonora, Mexico.

article thumbnail

First of its kind SARS-CoV-2 detection by partial N gene sequencing now publicly available at CLIA Certified Milford Connecticut laboratory

BioTech 365

First of its kind SARS-CoV-2 detection by partial N gene sequencing now publicly available at CLIA Certified Milford Connecticut laboratory First of its kind SARS-CoV-2 detection by partial N gene sequencing now publicly available at CLIA Certified Milford Connecticut laboratory … Continue reading →